EXOZYMES INC. Grants Receivable, Current
EXOZYMES INC. (EXOZ) had Grants Receivable, Current of $201.26 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Nontrade Receivables
us-gaap:GrantsReceivableCurrent · last filed 2026-08-13
- 2026-06-30: Grants Receivable, Current $201.26K.
- 2026-03-31: Grants Receivable, Current $302.86K.
- 2025-12-31: Grants Receivable, Current $517.36K.
- 2025-09-30: Grants Receivable, Current $302.64K.
| Period end | Grants Receivable, Current |
|---|---|
| 2026-06-30 | $201.26K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $302.86K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $517.36K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $302.64K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $257.41K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $595.16K 10-Q · filed 2026-05-14 |
| 2024-12-31 | $737.28K 10-Q · filed 2026-08-13 |
| 2024-09-30 | $553.96K 10-Q · filed 2025-11-13 |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $1.11M 10-Q · filed 2025-05-12 |
| 2023-12-31 | $882.32K 10-K · filed 2026-03-30 |
| 2023-09-30 | $676.45K 10-Q · filed 2024-11-12 |
| 2022-12-31 | $809.53K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |